Instil Bio Inc (TIL)
25.91
+1.15
(+4.64%)
USD |
NASDAQ |
Nov 22, 16:00
25.91
0.00 (0.00%)
After-Hours: 18:04
Instil Bio Total Liabilities (Quarterly): 96.23M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 96.23M |
| June 30, 2024 | 99.30M |
| March 31, 2024 | 100.48M |
| December 31, 2023 | 99.80M |
| September 30, 2023 | 106.25M |
| June 30, 2023 | 111.79M |
| March 31, 2023 | 116.02M |
| December 31, 2022 | 118.52M |
| Date | Value |
|---|---|
| September 30, 2022 | 122.15M |
| June 30, 2022 | 110.20M |
| March 31, 2022 | 56.38M |
| December 31, 2021 | 54.78M |
| September 30, 2021 | 45.98M |
| June 30, 2021 | 37.20M |
| March 31, 2021 | 30.99M |
| December 31, 2020 | 358.61M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
30.99M
Minimum
Mar 2021
358.61M
Maximum
Dec 2020
104.04M
Average
100.14M
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co Inc | 72.97B |
| Elite Pharmaceuticals Inc | 40.93M |
| BioCardia Inc | 3.514M |
| Zevra Therapeutics Inc | 121.78M |
| NovaBay Pharmaceuticals Inc | 2.805M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 272.56M |
| Shareholders Equity (Quarterly) | 176.33M |